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Abstract 
Tissue factor is highly expressed in sub-endothelial tissue. The extracellular allosteric 
disulfide bond Cys186–Cys209 of human tissue factor shows high evolutionary 
conservation and in vitro evidence suggests that it significantly contributes to tissue 
factor procoagulant activity. 
To investigate the role of this allosteric disulfide bond in vivo, we generated a C213G 
mutant tissue factor mouse by replacing Cys213 of the corresponding disulfide 
Cys190-Cys213 in murine tissue factor. 
A bleeding phenotype was prominent in homozygous C213G tissue factor mice. Pre-
natal lethality of 1/3rd of homozygous offspring was observed between E9.5 and 
E14.5 associated with placental hemorrhages. After birth, homozygous mice suffered 
from bleedings in different organs and reduced survival. Homozygous C213G tissue 
factor male mice showed higher incidence of lung bleedings and lower survival rates 
than females. In both sexes, C213G mutation evoked a reduced protein expression 
(about 10-fold) and severely reduced pro-coagulant activity (at least 100-fold). 
Protein glycosylation was impaired and cell membrane exposure decreased in 
macrophages in vivo. Single housing of homozygous C213G tissue factor males 
reduced the occurrence of severe bleeding and significantly improved survival, 
suggesting that inter-male aggressiveness might significantly account for the sex 
differences. 
These experiments show that the tissue factor allosteric disulfide bond is of crucial 
importance for normal in vivo expression, post-translational processing and activity of 
murine tissue factor. Although C213G tissue factor mice do not display the severe 
embryonic lethality of tissue factor knock-out mice, their postnatal bleeding 
phenotype emphasizes the importance of fully functional tissue factor for hemostasis. 
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Introduction 
Tissue factor (TF) is the cellular activator of the extrinsic pathway of blood 
coagulation. It is expressed in the sub-endothelial wall of blood vessels and organ 
parenchyma, leading to activation of coagulation after vessel injury. Levels of TF 
expression, however, differ significantly between organs: heart, brain, lung, and 
uterus exhibit very high TF expression, while TF is barely detectable in skeletal 
muscle and joints 1, 2. Total TF deletion in mice leads to embryonic death due to 
insufficient development of yolk sac vessels and vascular failure 3-5. A TF transgene 
inducing low expression of human full length TF (flTF) in mice (low-TF mice, ~1% of 
normal murine TF levels) is sufficient to rescue TF knockout mice from embryonic 
lethality 6 but not to restore normal postnatal hemostatic function. These mice suffer 
from spontaneous hemorrhages particularly in organs which in wild-type mice 
express high levels of TF such as heart, lung, brain, gastrointestinal tract, and testis 
7-9
. Fatal lung hemorrhages are very common in low-TF mice 8, 10 and are further 
enhanced when exposed to either intratracheal lipopolysaccharide 11 or infected with 
influenza A virus 12. Similarly, fatal brain hemorrhages have been observed in low-TF 
mice 10. Furthermore, female low-TF mice exhibit fatal hemorrhages in placenta and 
uterus during pregnancy and postpartum, suggesting that TF is crucial for uterine 
hemostasis 13. In line with these observations, tail bleeding time in low-TF mice was 
increased 14. 
Due to its sub-endothelial localization, TF is separated from circulating clotting factors 
in the absence of an injury. Minor amounts of TF are however expressed on the 
surface of monocytes and come in contact with blood 15, 16. To control pro-coagulant 
activity, TF activity is post-translationally suppressed by a mechanism called 
encryption 17. The mechanism of encryption is controversially discussed: several 
studies suppose that predominantly exposure of negatively charged phospholipids 
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account for the decryption of TF activity 18, 19, while others suggest activation via thiol 
disulfide exchange reactions 20-25 involving complement activation. Human TF indeed 
contains 2 disulfide bonds (Cys49-Cys57 and Cys186-Cys209) which are conserved 
in mice (Cys47-Cys55 and Cys190-Cys213) and many other species. The C-terminal 
bond shares sequence features of other allosteric disulfide bonds and is important for 
TF pro-coagulant activity 26 and thus crucial for regulation of TF activity in cell 
cultures 27, 28. Release of pro-coagulant, TF-containing extracellular vesicles (EV) 
from bone marrow-derived macrophages (BMDM) and smooth muscle cells was 
shown to be regulated by ATP stimulation of the purinergic receptor P2X7 29, also 
depending on thiol-exchange reactions 29. 
We generated a C213G TF knock-in (KI) mouse model to investigate the function of 
disulfide bond mutated TF in vivo and its contribution to hemostasis.  
 5 
Methods 
Construction of the C213G TF targeting vector 
The coding sequence of the murine full-length TF isoform containing a T721G 
mutation as well as the flanking genomic regions were inserted into KpnI/NotI 
restriction sites of a LNTK vector to replace the genomic TF locus. Embryonic stem 
cell transfection (129P2/OlaHsd) and blastocyst injection was conducted by 
PolyGene (Ruemlang, Switzerland). Chimeric mice were bred with C57BL/6J mice. 
 
Animals 
One mouse colony was bred of heterozygous animals on a mixed 129P2/OlaHsd-
C57BL/6J background (50% from each strain). Mice were backcrossed to C57BL/6J 
(B6). All tests performed were approved by the responsible authority of the local 
government. 
 
Embryonic analysis 
For embryonic analyses heterozygous C213G/+ TF mice were bred and females 
were controlled for plugs every morning (day of the plugs considered E0.5). 
 
Pathological analysis 
All organs were fixed in 4% buffered formalin and embedded in paraffin for 
histological examination. Four-µm-thick sections were cut and stained. 
 
Expression profiling 
Total RNA was isolated from organs just before microarray hybridization. Amplified 
RNA was hybridized and analyzed on Illumina MouseRef8 v2.0 Expression Bead 
Chips containing about 25K probes.  
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Bleeding time 
After onset of anesthesia, tails were prewarmed in a 37°C water bath for 10 min. 
Then 0.5 mm of the tail tip was amputated, and the tail was immediately put back to 
37°C PBS.  
 
Tail-cuﬀ blood pressure measurement 
Blood pressure was measured in non-anesthetized mice with a non-invasive tail-cuﬀ 
method using the MC4000 Blood Pressure Analysis Systems.  
 
TF expression analysis 
RNA was extracted using TRIzol Reagent (Molecular Research Center). Transcript 
levels were quantified by Real Time PCR using SyBr Green Master Mix on an 
Applied Biosystems 7300 System. Protein was extracted by grinding of organ tissue 
in lysis buffer. Samples were separated by 10% SDS-PAGE and transferred to a 
PVDF membrane (Immobilion®-FL, Millipore). The membrane was stained with anti-
mouse TF rabbit antiserum (R8084) 29 and anti-human GAPDH (cross-reactive to 
mouse) mouse monoclonal (MAB374, Millipore) primary antibodies, followed by 
secondary antibodies.  
 
TF activity  
Tissue was lysed in HEPES-saline containing 0.02% sodium azide (HBS) and diluted 
in HBS containing 1mg/ml BSA and 50 µM phospholipid vesicles to measure TF 
activity using a plasma clotting assay.  
 
Macrophage experiments 
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Femora and tibiae were dissected and flushed with RPMI. Cells were resuspended in 
90% FCS, 10% DMSO. Bone marrow-derived macrophages (BMDM) were generated 
from total bone marrow cell cultures as described previously 30. Cell surface TF 
activity was determined with 0.5 nM FVIIa and 50 nM FX in HBS by measuring a time 
course of FXa generation. TF EV activity was measured in HBS with 2 nM VIIa and 
100 nM FX. EV prothrombinase activity was measured in HBS with 10 nM FVa, 5 nM 
FXa and 500 nM prothrombin. RNA was isolated from macrophages using TRIzol 
Reagent. Transcript levels were quantified by Real Time PCR. 
 
Statistical analyses 
Data are indicated as mean ± SEM. Unpaired Student’s t-test and two-way ANOVA 
were used as appropriate. For comparison of genotype distributions, a X2-test was 
applied. A p value <0.05 was considered as significant.  
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Results 
 
Generation of C213G TF KI mice 
To generate mice expressing C213G TF under the control of the endogenous TF 
promoter, a replacement-type targeting vector was cloned. This vector contained the 
coding sequence of C213G full length TF, which was flanked by 3kb 5’ and 5.2kb 3’ 
arms of homology; thus, the endogenous TF sequence was replaced by the C213G 
TF coding sequence by homologous recombination (Figure 1A). 
 
Partial developmental lethality in homozygous C213G TF offspring 
Heterozygous mice were bred, and among 889 offspring on a C57BL/6J genetic 
background, 141 homozygous C213G/C213G (16.1%) TF, 508 heterozygous 
C213G/wt TF (57.5%), and 240 (26.4%) wt animals were found at weaning. At birth, 
among 320 offspring, 56 homozygous C213G/C213G (17.5%), 170 heterozygous 
C213G/wt (53.1%), and 94 wt (29.4%) were found, excluding significant post-natal 
lethality (Figure 1B). Thus, 1/3 of homozygous C213G/C213G pups were missing at 
birth and both genotype distributions at weaning and at birth differed significantly 
from a mendelian distribution. 
Genetic deletion of the TF gene in mice leads to embryonic lethality between 
embryonic day (E) 9.5 and 10.5 3. To determine whether homozygous C213G/C213G 
TF embryos are generated at mendelian ratios, 70 E9.5 embryos on a B6 genetic 
background were genotyped. Eighteen homozygous C213G/C213G TF (25.7%), 34 
heterozygous C213G/wt TF (48.6%), and 18 wt (25.7%) embryos were found, which 
goes along with mendelian segregation (Figure 1B). In contrast to TF KO mice, 
histology did not show any impairment of yolk sac vessel integrity and normal levels 
of α-SMA expression in homozygous C213G/C213G TF yolk sacs at E9.5 
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(Supplemental Figure 1A) 3. At embryonic day 14.5, 11 vital homozygous 
C213G/C213G TF (16.4%), 34 heterozygous C213G/wt (50.8%) and 22 wt embryos 
(32.8%) were found, indicating that C213G/C213G TF mice show partial 
developmental lethality between day 9.5 and 14.5. Embryonic growth required 
umbilical blood flow via the chorioallantoic placenta from day 10.5 31. Besides the 11 
vital homozygous C213G/C213G TF embryos, 3 necrotic homozygous embryos 
could be identified on day 14.5 showing retinal pigmentation which indicates 
development to at least E11.5 32. Additional resorbed implantation sites were present, 
which could not be genotyped. Placentas of both vital and necrotic homozygous 
C213G/C213G TF embryos showed hemorrhages of variable number and size 
(Supplemental Figure 1A).  
 
Decreased survival of adult homozygous C213G/C213G TF offspring 
Between the age of 3 to 4 weeks, about 10% homozygous C213G/C213G TF mice 
on B6 background developed a hydrocephalus, while this was not observed in 
C213G/C213G TF animals on a mixed background (data not shown). This may be 
due to the tendency of wt B6 mice to develop spontaneous hydrocephalous 33. 
With progressing age some homozygous C213G/C213G TF mice developed 
symptoms of disease, mostly dyspnea, apathy and weight loss, but sometimes also 
neurological symptoms or spontaneous death. Diseased animals were euthanized 
when they met defined termination criteria. Both euthanized animals and those which 
died were included in the survival analysis. We found a sex difference in survival with 
impaired survival of male homozygous C213G/C213G TF mice. The sex difference 
was more pronounced in animals on a mixed background (p<0.001) compared to 
animals on a B6 background (p=0.17, Figure 1C). Dissection of dead and euthanized 
mice showed macroscopic bleedings to heart, lung, and brain, which are organs with 
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high TF expression. Hemorrhages were confirmed microscopically in heart, lung, and 
brain (Figure 2 A-D). They were accompanied by secondary changes like epi- and 
myocarditis and fibrosis in hearts as well as edema (Figure 3A-B), bronchiolitis 
obliterans, and pneumonia in lungs. 
 
Sex difference in organ pathology 
In order to quantify the incidence of organ bleedings, we analyzed a group of male 
and female homozygous C213G/C213G TF mice on a B6 background without 
apparent disease symptoms. This analysis of asymptomatic mice provided a 
measure for the incidence of organ bleedings in a uniform group of mice of both 
sexes of the same age. At 17 weeks of age we found a similar incidence of 
hemorrhages in heart (7/11 in females and 5/10 in males) and brain (2/11 in females 
and 2/10 in males) of male and female homozygous C213G/C213G TF mice, while 
the incidence of lung hemorrhage was more pronounced in males (5/10) as 
compared to females (1/11) (Supplemental Figure 1B). Lungs of male homozygous 
C213G/C213G TF mice also exhibited macroscopically more hemorrhagic areas in 
comparison to female mice and these were accompanied by edema in severe cases 
(Figure 2A). Histologically, affected areas showed intra-alveolar hemorrhage and the 
presence of macrophages, eosinophilic fibrillar material in bronchial lumen, and peri-
vascular and peri-bronchial inflammatory infiltrates (Figure 2B). In contrast to 
reported calcified testes in low-TF mice 9, we did not observe calcification of testes 
(Supplemental Figure 2A). 
Epi- and myocardial hemorrhages (Figure 2C) as well as inflammation representing 
myocarditis (Figure 3A) were observed in hearts of homozygous C213G/C213G TF 
mice. Furthermore, fibrotic changes were detectable in all hearts of homozygous 
C213G/C213G TF mice, even without acute hemorrhage or inflammation (Figure 3B).  
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However, blood pressure and heart rate of male and female C213G/C213G TF mice 
were comparable to that of male and female wt TF mice (Supplemental Fig. 2B).  
 
Molecular changes in heart and lung of C213G/C213G TF mice 
Using Illumina Bead array, we assessed gene expression profiles in hearts and lungs 
of male and female homozygous C213G/C213G TF mice compared to the mean 
expression values of wt TF mice (Figure 3C, Supplemental Table 1). 113 genes were 
significantly regulated in male and 178 genes in female C213G/C213G TF mouse 
hearts. GO-terms which were both overrepresented in hearts of homozygous male 
and female C213G/C213G TF mice were cellular movement, hematological system, 
immune cell trafficking, cancer, cardiovascular system, cellular growth and 
proliferation, skeletal and muscular disorders, cell-to-cell signaling and interaction, 
metabolic disease, cardiovascular disease, respiratory disease, and cell death. This 
is in line with inflammation and fibrotic remodeling. In male C213G/C213G TF mouse 
lungs 69 genes were significantly upregulated and classified to the following 
overrepresented GO terms: inflammatory response, cellular movement, cell-to-cell 
signaling, hematological system, connective tissue, cancer, respiratory disease, 
cardiovascular disease, and lipid metabolism. In contrast, in female C213G/C213G 
TF mouse lungs only 23 genes were weakly regulated (fold change of -3.66 to 2.10) 
while no GO term was overrepresented. Although the macroscopically least affected 
lungs were selected for the analysis, the differential gene regulation in male 
C213G/C213G TF lungs compared to females suggests increased early pathological 
alterations and supports the sex difference in lung pathology. 
 
Tail bleeding time and blood cell counts 
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Tail bleeding was measured to investigate whether primary differences exist in 
hemostatic capacity. Tail bleeding time was prolonged in homozygous 
C213G/C213G TF mice of both sexes, but no difference was detected between the 
sexes (Figure 4A). Comparing blood counts of C213G/C213G TF mice to wt mice 
revealed a mild decrease of cellular hemoglobin content (MCH) and concentration 
(MCHC), slightly increased reticulocyte numbers with more immature reticulocytes, 
and an increased mean platelet size due to a higher proportion of big platelets (>12fl) 
in homozygous C213G/C213G TF mice (Figure 4B). Even though these findings are 
consistent with compensated chronic bleedings, the absolute change of the values 
was small. 
 
TF expression and activity 
TF mRNA expression was measured in heart, brain, and lung of male and female 
homozygous C213G/C213G TF and wt mice using flTF specific primers (Figure 5A). 
flTF expression was slightly elevated in brain and lung of homozygous 
C213G/C213G TF mice compared to wt mice. In hearts of male C213G/C213G TF 
mice, flTF mRNA was significantly increased by 9.6 times compared to hearts of wt 
mice suggesting a compensatory transcriptional induction of a functionally insufficient 
protein that may involve recently demonstrated feedback loops of the TF cytoplasmic 
domain34. In C213G/C213G TF female hearts a similar induction was seen, however 
with a higher variability.   
Induction of TF transcription is in line with inflammatory and fibrotic remodeling seen 
in all hearts of both genders. To assess the protein expression and activity of C213G 
TF, organ lysates were prepared from heart, brain and lung. Protein expression of 
C213G TF was 10 times lower than expression of wtTF in brain and lung. In hearts, 
protein expression of C213G TF and wtTF did not differ (Figure 5B), in line with the 
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compensatory upregulation of gene transcription. Pro-coagulant activity was 
measured using a plasma clotting assay. Pro-coagulant activity of brain and lung 
lysates from C213G/C213G TF mice was decreased about 1000-fold compared to wt 
TF brains and lungs. In heart lysates, the difference in pro-coagulant activity was only 
about 100-fold (Figure 5C). A 10-fold reduction of protein expression in brains and 
lungs of C213G/C213G TF mice is in line with a 10-fold stronger decrease in pro-
coagulant activity as compared to heart. In both genotypes, there was no difference 
between the sexes, neither in expression nor in pro-coagulant activity. 
 
The TF allosteric disulfide is required for TF procoagulant function in 
macrophages 
We characterized the pro-coagulant activity of the C213G TF mutant in primary bone 
marrow-derived macrophages. In order to assure unaltered induction of TF in IFNγ 
primed and 4 hour LPS stimulated macrophages 29, 30, we measured TF mRNA levels 
with flTF-specific primers (Figure 6A). flTF mRNA levels were significantly higher in 
C213G/C213G TF macrophages which is expected as in these cells both alleles of 
endogenous TF (yielding fully processed mRNA for flTF and asTF) were replaced 
with a gene that only yields the mutated flTF. Given the unimpaired mRNA induction, 
we next measured TF protein expression 90 minutes and 4 hours after LPS 
stimulation (Figure 6B). While TF induction was below the detection limit in the 
absence of IFNγ priming, a low molecular ~48 kDa form of TF was expressed after 
90 minutes of stimulation in both IFNγ-primed wt and C213G/C213G TF 
macrophages. After 4 hours of stimulation, wt TF was predominantly expressed as a 
highly glycosylated protein which was not detected in macrophages from 
C213G/C213G TF mice.  
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Since glycosylation of TF is required for cell surface expression and procoagulant 
activity in intestinal epithelial cells 35, we next tested the procoagulant activity of intact 
macrophages. Macrophage cell surface TF is largely inactive and requires activation 
of the P2X7 receptor with ATP. C213G/C213G TF macrophages displayed minimal 
procoagulant activity on their cell surface after ATP stimulation and no TF activity or 
antigen was detected on EV released from these cells (Figure 6C-D). Western 
Blotting for other proteins typically released on ATP-induced EV36 revealed no 
quantitative abnormalities in EV release from C213G/C213G TF macrophages, 
demonstrating that TF is selectively absent in EV derived from C213G/C213G TF 
macrophages (Figure 6D). In addition, measurements of prothrombinase activity 
showed that the release of procoagulant lipids on EV was not different between wild-
type and C213G/C213G TF macrophages (Figure 6C). Thus, mutation of the 
allosteric disulfide of TF prevents glycosylation and normal cellular processing, 
leading to a severely impaired procoagulant activity in macrophages stimulated with 
inflammatory mediators. 
  
Behavioral differences 
Having excluded that primary differences in protein expression and activity as well as 
general hemostatic capacity exist between the sexes, we investigated whether 
behavioral differences of male and female mice may underlie differences in disease 
severity in homozygous C213G/C213G TF mice. At the age of 21 days, 12 
homozygous C213G/C213G TF males were weaned to individual cages and housed 
individually up to the age of 100 days to prevent aggressive fighting. All 12 males 
survived to the age of 100 days, which is a significant improvement compared to 
group housed males (p=0.0326) (Figure 7A). After day 100, pulmonary hemorrhages 
were detected in 3 out of 12 (25%) single housed homozygous C213G/C213G TF 
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males (Figure 7B), in comparison to 50% lung hemorrhages in homozygous 
C213G/C213G TF group housed males. This experiment demonstrates that lung 
hemorrhages develop spontaneously in homozygous C213G/C213G TF males, but 
single housing reduces the risk for lung bleedings and lowers mortality. 
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Discussion 
After the description of the importance of the TF C-terminal disulfide bridge for TF 
pro-coagulant activity 26 and evidence for its involvement in TF decryption 20, 21, 27 it is 
crucial to understand its significance in an in vivo model. In the C213G TF mouse 
model we observed changes similar to those previously reported in vitro: reduced 
protein expression, glycosylation, and surface translocation. In line with this, the pro-
coagulant activity is reduced by at least a factor 100 independent of changes in 
protein expression. The C213G TF mutant still exhibits sufficient pro-coagulant 
activity to ensure embryonic development in 2/3rd of offspring and to allow early post-
natal survival. 
The overall phenotype of C213G/C213G TF mice shows impressive similarity to the 
phenotype of low-TF mice, which express a human TF transgene in the absence of 
mouse TF. Pro-coagulant activity in low-TF mice was estimated 1% of normal levels 
resulting from low expression of TF under the control of the human promoter 6. 
However, low-TF mice are born in accordance with Mendelian ratios 6, while C213G 
TF mice displayed a reduced number of homozygous C213G/C213G TF offspring at 
birth. Partial developmental lethality is observed when other clotting factors (Factor V, 
Prothrombin) or the thrombin receptor PAR1 are knocked out 37-39. Deficiency in 
PAR2, which is activated by the TF/FVIIa complex, results in a partial, but undefined 
developmental lethality 40, suggesting that thrombin generation and PAR1 signaling, 
but not PAR2 signaling, are crucial for development. Rescue experiments of murine 
TF (mTF) ko using different human TF transgenic lines suggested that the threshold 
of TF activity needed to support embryonic development is lower than that needed to 
maintain postpartum hemostasis, as some transgenic lines quantitatively rescue 
genetic deletion of mTF but rescued pups die days or weeks after birth 41. For 
C213G/C213G TF embryos this either suggests that expression under the 
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endogenous mTF promoter may lead to different spatio-temporal expression patterns 
associated with different thresholds or that certain signaling functions of C213G TF 
are altered, whose importance for development has not been recognized yet. Given 
the placental hemorrhages observed in homozygous C213G/C213G TF mice, 
placental insufficiency might contribute to the partial developmental lethality in the 
latter and is in line with the low-TF phenotype exhibiting blood pooling in placentas of 
low-TF embryos at E14.5 13. 
Reduced survival of low-TF mice was mainly attributed to impaired left ventricular 
function induced by myocardial hemorrhages and fibrosis 6. Development of cardiac 
fibrosis was found to be sex-dependent with lower severity in female mice and 
associated with downregulation of fibrinolytic urokinase plasminogen activator 42. 
Although there was a sex-dependent effect on the development of cardiac fibrosis, 
no difference in survival was described between the sexes. No changes in heart rate, 
systolic, diastolic, or mean arterial blood pressure was found in C213G/C213G TF 
mice, suggesting that the myocardial fibrosis did not fully translate into cardiac 
dysfunction. At the mRNA level, cardiac TF expression was about ten times higher in 
C213G/C213G TF mice as compared to wt TF mice. This increase translated in a 
similar cardiac protein expression in C213G/C213G TF mice and wt TF mice – in 
contrast to lung and brain, where protein expression was lower in C213G/C213G TF 
mice. This observation is consistent with a compensatory elevation of transcription 
and may in part explain the unaltered hemodynamic parameters. 
C213G/C213G TF males showed lower survival as compared to females; however, 
from autopsies of dead or terminally ill mice it was difficult to define the exact cause 
of death, particularly when all the three organs brain, heart, and lung showed 
hemorrhages. We therefore analyzed the incidence of sub-lethal hemorrhages in a 
uniform cohort of male and female C213G/C213G TF and wt TF mice, assuming that 
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the incidence of sub-lethal hemorrhages correlates with the incidence of terminal 
hemorrhages. In this healthy appearing cohort, we found a considerable degree of 
cardiac fibrosis in 100% of C213G/C213G TF mice, and the level of fibrosis did not 
differ between male and female mice. However, male C213G/C213G TF mice 
showed a higher incidence of lung bleedings compared to females as well as a 
differential pulmonary gene expression pattern. This suggests that in C213G/C213G 
TF mice, lung hemorrhages may represent the main reason for terminal disease. To 
address the question why male C213G/C213G TF mice are more prone to lung 
bleedings than female C213G/C213G TF mice, we investigated possible molecular 
differences in TF expression between the genders or functional differences in 
bleeding time. As neither of these parameters showed a difference between female 
and male homozygous C213G/C213G TF mice, we hypothesized that behavioral 
differences, in particular aggressive fighting, leads to aggravated pulmonary 
hemorrhage in homozygous C213G/C213G TF males. Inter-male aggression is a well 
known problem in housing of male laboratory mice, which can be modulated by 
genetic background as well as cage enrichment 43. Cases of exercise induced 
pulmonary hemorrhage exist in healthy humans 44, 45 and spontaneous pulmonary 
hemorrhages are a known complication of anticoagulant therapy 46-49. Single housing 
indeed reduced the incidence of pulmonary hemorrhages and significantly improved 
survival of homozygous C213G/C213G TF male mice with low pulmonary TF activity, 
suggesting that fully active TF is protective against spontaneous and exercise 
induced pulmonary hemorrhages. A previous report suggested that fatal lung 
hemorrhages may also represent a major reason for reduced survival of low-TF mice 
8
. In line with this, 17% of low-TF mice die of spontaneous hemorrhages in lung, 
brain, and gastrointestinal tract, 7, 10. 
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In contrast to low-TF mice 9, we did not observe any testis calcification in 
C213G/C213G TF male mice. The morphology of the seminiferous tubules of the 
testis and the general sperm amount in the cauda epididymis seemed normal. Since 
the corresponding single Cys replacement in human TF is compatible with TF-FVIIa 
signaling21, one possible explanation for these differences is preservation of integrin-
dependent TF signaling50 in the context of testes physiology.  
In conclusion, mutation of the allosteric disulfide bond of TF leads to some reduction 
in protein expression and a pronounced reduction in protein activity of at least 100-
fold which goes along with impaired glycosylation and cell surface expression. This 
impairment results in a bleeding phenotype causing partial developmental lethality 
and high susceptibility of lung, brain, and heart to bleedings after birth. Male mice 
exhibit more frequent and severe lung hemorrhages, which can be reduced by single 
housing preventing inter-male aggression. Thus, this study emphasizes the 
importance of the allosteric disulfide for proper TF expression, modification and 
function in vivo and the importance of functional TF for developmental and post-natal 
hemostasis and survival. 
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Figure legends 
Figure 1: Genetic targeting, genotype distributions and survival. (A) The murine 
TF allele was targeted with a replacement-type vector containing the murine flTF 
coding sequence with T721G nucleotide exchange in exon 5, flanked by 3 kb 5’ and 
5.2 kb 3’ homology arms. Diphtheria toxin (dt) was used for negative selection. After 
homologous recombination into 129P2/OlaHsd embryonic stem cells, a loxP flanked 
neomycin resistance cassette was removed by transfection with a Cre expression 
plasmid. (B) Genotype distribution of offspring from heterozygous breeding pairs on a 
B6 background were analyzed at different time points. Genotype distributions were 
compared to a mendelian 25%/50%/25% distribution as well as to the distributions at 
other time points. (C) Reduced survival of homozygous C213G TF mice. Survival 
curve of homozygous male and female C213G/C213G TF offspring on mixed and B6 
genetic background (male mixed n=32, female mixed n=32, male B6 n=32, female 
B6 n=43). Dead and diseased mice meeting the termination criteria were both 
included in the analysis.  
 
Figure 2:  Figure 2:  Macroscopic images of lung hemorrhages and iron 
detection (Prussian Blue staining) in heart, lung and brain hemorrhages. (A) 
Representative macroscopic images of lung bleedings in male and female 
homozygous C213G/C213G TF mice. (B) Lung, (C) heart, and (D) brain consecutive 
sections from wt and homozygous C213G/C213G TF mice were stained with 
hematoxylin and eosin (H&E) for morphological analysis and Prussian Blue to show 
ferric iron (Fe3+) in blood. The area of the higher magnification pictures (20x) is 
demarcated with a rectangle in the lower magnification ones (aprox. 1.45x in 
heart/brain and 5x in lung). Iron deposits within lung macrophages are particularly 
obvious in B. 
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Figure 3: Histological images of myocarditis and myocardial fibrosis, gene 
profile in heart and lung tissue. (A) Heart sections of wt and homozygous 
C213G/C213G TF mice were stained with hematoxylin and eosin (H&E). Immune 
infiltrates are visible in the myocardium of C213G/C213G TF animals. The area of the 
higher magnification picture (40x) is shown with a rectangle in the lower magnification 
one (15x). (B) Consecutive sections from wt and homozygous C213G/C213G TF 
mice were stained with hematoxylin and eosin (H&E) for morphological analysis and 
Picro-sirius Red for better visualization of collagen. The area of the higher 
magnification (20x) pictures is demarcated with a rectangle in the lower magnification 
ones (aprox. 1.45x). (C) Heatmaps of significantly (FDR<10%) regulated genes 
between homozygous C213G/C213G TF and wt mice in heart and lung tissues. 
Genes are shown, if they are regulated in either male or female animals per tissue. 
Yellow (blue) indicates down (up) regulation compared to the mean expression of wt 
mice. 
 
Figure 4: Bleeding time and blood counts. (A) Bleeding times after amputation of 5 
mm tail tip; male wt n=19, female wt n=13, male C213G/C213G n=15, female 
C213G/C213G n=11; **p<0.01, ***p<0.001. (B) Blood count analysis in 
C213G/C213G TF and wt mice in with Sysmex XT-2000iV. Some of the values where 
significantly different between C213G/C213G TF mice and wt TF mice. However, 
absolute differences were all minor. 
 
Figure 5: TF expression and activity in brain, lung and heart. (A) Semi-
quantitative RT-PCR in brain, lung, and heart of male and female homozygous 
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C213G/C213G TF mice and wt TF mice using flTF-specific primers and normalization 
for β-actin (n=6, *p<0.05). (B) Representative blots and quantification of TF protein 
expression in brain, lung and heart of male and female homozygous C213G/C213G 
TF mice and wt TF mice (n=4, **p<0.01, ***p<0.001). (C) Plasma clotting time 
measurements of TF activity in brain, lung and heart of male and female homozygous 
C213G/C213G TF and wt TF mice (n=4, **p<0.01, ***p<0.001). 
 
Figure 6: TF expression and EV release in bone marrow-derived macrophages. 
(A) TF mRNA levels were determined by semi-quantitative RT-PCR using flTF-
specific primers and normalization for β-actin. Bone marrow-derived macrophages 
cultured overnight without or with IFNγ (100 ng/ml) were stimulated with 1 mg/ml LPS 
for 4 hours; wt n=5, C213G/C213G n=4; ***p<0.001. (B) Western-blotting for TF with 
a polyclonal anti-mouse TF antibody of membrane fractions from macrophages with 
or without overnight IFNγ priming stimulated with 1 mg/ml LPS for the indicated times 
(representing two independent experiments). (C) TF cellular and EV activity 
measured by FXa generation assay of INFv primed and LPS stimulated 
macrophages with or without activation of the P2X7 receptor with 5 mM ATP for 30’; 
n=3, *p<0.05, **p<0.01. Prothrombinase activity of the same EV preparations was 
determined as a measure for the release of procoagulant, PS-expressing MP. (D) 
Protein composition of EV released after ATP stimulation for 30’ was evaluated by 
Western-blotting for TF, integrin b1, and b-actin. Densitometric quantification of 
protein levels from 3 independent experiments showed that levels on EV from 
C213G/C213G TF macrophages were 1.4 ± 1.1 for integrin b1 and 1.4 ± 1.7 for b-
actin relative to wt-derived EV levels (representing two independent experiments).   
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Figure 7: Single housing reduces incidence of lung bleedings and lethality in 
homozygous C213G/C213G male mice. (A) All 12 single housed C213G/C213G TF 
males survived up to 100 days, in contrast to C213G/C213G TF males, which were 
group housed (n=32). (B) Incidence of lung bleedings was reduced from 50% to 25% 
in homozygous C213G/C213G TF males. 
 







Supplemental material: Methods 
Construction of the C213G TF targeting vector 
The vector generated for murine TF (mTF) targeting is a replacement-type vector 
containing two long arms of homology. The coding sequence of the murine full length 
TF isoform containing a T721G mutation in its open reading frame was inserted into 
KpnI/NotI restriction sites of a LNTK vector (PolyGene AG, Ruemlang, Switzerland) 
located 5’ to a neomycin resistance gene, flanked by two loxP sites (floxed neo). A 3 
kb genomic sequence 5’ upstream of the first exon of the TF gene, and a 5.2 kb 
Bsp120I/NotI restriction fragment located 3’ downstream of the last exon of the TF 
gene, were used as the left and the right arms of homology, respectively. A 
diphtheria toxin alpha chain minigene (dtα) under the control of the DNA polymerase 
II promoter served as a negative selection marker; dtα was inserted into the targeting 
vector on its 3‘-end as a 1.2 kb Bsp120I/NotI restriction fragment. The targeting 
vector was linearized on the NotI restriction site located on its 3‘-end prior to 
electroporation. Embryonic stem cell transfection (129P2/OlaHsd), screening, 
neomycin excision as well as blastocyst injection was conducted by PolyGene AG 
(Ruemlang, Switzerland). Chimeric mice were bred with C57BL/6J mice. 
 
Animals 
One mouse colony was maintained by breeding of heterozygous animals on a mixed 
129P2/OlaHsd-C57BL/6J background with a mean of 50% from each background 
strain. In parallel, mice were backcrossed to C57BL/6J (B6) by a speed congenic 
approach: from each generation the two offspring with the highest percentage of B6 
background was chosen for further backcrossing. The genetic background was 
analyzed screening 96 polymorphic microsatellite markers (Elchrom Scientific AG, 
Cham, Switzerland). After 5 backcrosses 3 mice had reached 100% B6 background 
and founded a B6 colony, which was maintained by breeding of heterozygous 
animals. After the discovery of a strain phenotype with increased lethality, the 
animals were checked daily and euthanized, when they developed pronounced 
affliction (apathy, dyspnea, neurological symptoms). Dead and euthanized strained 
animals were both included in the survival analysis with their age at death or 
euthanasia. Two cohorts of mice derived from the B6-colony were used for systemic 
phenotyping including hematological analyses and blood pressure measurement. 
Mice were maintained in individually ventilated cages with water and standard mouse 
chow (Altromin no. 1314) according to the institutional housing conditions and local 
laws. All tests performed were approved by the responsible authority of the local 
government. 
 
Embryonic analysis 
For embryonic analyses heterozygous C213G/+ TF mice were bred and females 
were controlled for plugs every morning. The day of the plug was considered to be 
E0.5. 
At E9.5, uteri were fixed with 4% formalin in PBS for at least 4 days. Using a razor 
blade, individual implantation sites were separated and each implantation site was 
halved transversely to the uterus. A piece of embryonic or yolk sac tissue was taken 
from one half and washed with PBS before genotyping, the other half was put back to 
4% formalin in PBS. After genotyping, the remaining half was embedded to paraffin 
and sectioned to do immunohistochemical staining of smooth muscle α-actin (Sigma, 
F3777). 
At E14.5 uteri were dissected, a piece of yolk sac was taken from every implantation 
site for genotyping, while fetus and placenta were fixed in 4% formalin in PBS. 
 Pathological analysis 
C213G/C213G TF (11 female and 10 male) and control (5 female and 5 male) mice 
were sacrificed according to approved protocols and all organs were examined 
macroscopically during necropsy. For microscopical analysis, 30 organs (see 
www.mouseclinic.de for more info) were immersion-fixed in 4% neutral buffered 
formalin and subsequently embedded in paraffin. Four-micrometer thick sections 
were either stained with hematoxylin and eosin (H&E) for general histological 
analysis, Picro-sirius Red for better visualization of collagen or Prussian Blue for iron 
deposits. Finally, slides were scanned using a Hamamatsu NanoZoomer 2.0HT 
digital scanner and analysed with NDP.view2 software (Hamamatsu Photonics, 
Japan). 
 
Expression profiling 
Total RNA was isolated from organs just before microarray hybridization. Organs 
(heart, lung and brain) were thawed in Trizol Reagent (Sigma), homogenized using a 
Polytron homogenizer (Heidolph) and total RNA was extracted from individual 
samples using RNeasy Midi kits (Qiagen) following the manufacturer’s protocol. 2 µg 
RNA aliquots were run on a formaldehyde agarose gel to check for RNA integrity and 
concentrations were calculated from OD260/280 measurement. The RNA was stored 
at -80°C in RNase free water (Qiagen). 
Four biological replicates for each genotype group were performed (four mutants and 
four controls). Therefore, 500 ng of total RNA was amplified and biotinylated in a 
single round using the Illumina TotalPrep RNA Amplification Kit (Ambion). 750 ng of 
albelled and amplified RNA was hybridized on Illumina MouseRef8 v2.0 Expression 
Bead Chips containing about 25K probes. Staining and scanning (Illumina HiScan 
Array Reader) was done according to the Illumina expression protocol. 
 
Bleeding time 
After onset of anesthesia, tails were prewarmed in a 37°C water bath for 10 min. 
Then 0.5 mm of the tail tip was amputated and the tail was immediately put back to 
37°C PBS. The time to cessation of bleeding was measured. 
 
Blood Withdrawal and Storage 
Blood samples were collected from isoflurane-anesthetized mice from the retro-
bulbar sinus with non-heparinized glass capillaries (1.0 mm in diameter; Neo- 
lab; Munich, Germany). A proportion of 50µl was collected in an EDTA-coated end-
to-end capillary and diluted 1:5 with CellPack buffer in prefilled capillary tubes 
(Sysmex, Art.No 99940020) and mixed thoroughly for hematological measurements. 
Samples were placed on a rotary agitator at room temperature for until analysis. 
 
Hematology 
Diluted samples were used to determine complete blood cell counts using a Sysmex 
XT2000iV device (Sysmex Deutschland GmbH, Norderstedt, Germany) by applying 
the capillary mode according to the instructions of the manufacturer as described 
previously1 
 
Tail-cuff blood pressure measurement 
Blood pressure was measured in non-anesthetized mice with a non-invasive tail-cuff 
method using the MC4000 Blood Pressure Analysis Systems (Hatteras Instruments 
Inc., Cary, North Carolina, USA). Four animals were restrained on a pre-warmed 
metal platform in metal boxes. The tails were looped through a tail-cuﬀ and fixed in a 
notch containing an optical path with a LED light and a photosensor. The blood pulse 
wave in the tail artery is detected as transformed into an optical pulse signal by 
measurement of light extinction. Pulse detection, cuﬀ inflation and pressure 
evaluation are automated by the system software. After five initial inflation runs for 
habituation, 12 measurement runs are performed for each animal in one session. 
Runs with movement artifacts are excluded. After one day of training, in which the 
animals are habituated to the apparatus and protocol, the measurements are 
performed on four consecutive days between 8:30 and 11:30 AM. 
 
TF expression analysis 
RNA was extracted from heart, lung or brain using TRIzol Reagent (Molecular 
Research Center), according to the manufacturer’s protocol. Five µg of total RNA 
were used to synthesize cDNA using reverse transcriptase (Stratagene, La Jolla, CA) 
and random hexamer primers. Transcript levels were quantified by Real Time PCR 
using SyBr Green Master Mix (Applied Biosystems) on an Applied Biosystems 7300 
System using primers specific for flTF: 5’ TCAAGCACGGGAAAGAAAAC (TF 
forward) and 5’ CTGCTTCCTGGGCTATTTTG (TF reverse) and normalized for β-
actin levels. Relative expression levels represent multiples of ten of 2(Ct[flTF]-Ct[β-actin]). 
Protein was extracted by manual grinding of organ tissue in lysis buffer containing 50 
mM octylglucoside, 50 mM Tris, 150 NaCl, 10 µg/µl aprotinin and 10 µg/µl leupeptin 
pH 7.4. Lysates were precipitated with -20°C aceton overnight and resuspended in 
non-reducing sample buffer with careful sonication. Samples were separated by 10% 
SDS-PAGE and transferred to a PVDF membrane (Immobilion®-FL, Millipore). The 
membrane was stained with anti-mouse TF rabbit antiserum (R8084) 2 and anti-
human GAPDH (cross-reactive to mouse) mouse monoclonal (MAB374, Millipore) 
primary antibodies, followed by staining with goat anti-rabbit 800CW and donkey anti-
mouse 680 LT (both LI-COR® Biosciences) secondary antibodies. Staining was 
visualized on an Odyssey imager and quantified using the corresponding application 
software (version 3.0; both LI-COR® Biosciences) 
 
TF activity  
At E9.5 uteri were dissected. Tissues were snap-frozen and yolk sacs were used for 
genotyping. Tissues were lysed in HEPES-saline containing 0.02% sodium azide 
(HBS) and diluted in HBS containing 1mg/ml BSA and 50 µM phospholipid vesicles 
(70% phosphatidylcholine (PC) and 30% phosphatidylserine (PS), Avanti polar lipids) 
to measure TF activity using a plasma clotting assay. Human and mouse citrated 
plasma was mixed 9:1 (50µl) and prewarmed together with the sample (50µl) or a 
reference (recombinant lipidated human TF, American Diagnostica). After addition of 
25 mM CaCl2 (50µl) clotting times were measured. Clotting times were normalized to 
a standard curve and the total protein concentration of the sample. 
 
Color coded gene regulation profiles  
Illumina Genomestudio 2011.1 software was used for background correction and 
normalization of the data (quantile algorithm). The remaining negative expression 
values were corrected by introducing an offset. The identification of significant gene 
regulation was performed using SAM (Significant Analysis of Microarrays) included in 
the TM4 software package. Genes were ranked according to their relative difference 
value d(i), a score assigned to each gene on the basis of changes in gene 
expression levels relative to the standard deviation. Genes with d(i) values greater 
than a threshold were selected as significantly differentially expressed in a one class 
analysis. The percentage of such genes identified by chance is the false discovery 
rate (FDR). To estimate the FDR, nonsense genes were identified by calculation 
1000 permutations of the measurements. The selection of the top differentially 
expressed genes with reproducible up- or down-regulation includes less than 10% 
false positives (FDR) in combination with fold change > 1.5. 
Functional enrichment analyses were generated through the use of QIAGEN’s 
Ingenuity Pathway Analysis (IPA®, QIAGEN Redwood City, 
www.qiagen.com/ingenuity) and using GePS software (Genomatix, Germany) 
 
Macrophage experiments 
Isolation and freezing of bone marrow cells: Femura and tibiae were dissected and 
cleaned from soft tissue. After removing the epiphyses, bones were flushed with 
RPMI. Bone marrow was suspended by pipetting and cells were counted. After 
centrifugation at 200 g, cells were resuspended in 90% FCS, 10% DMSO and slowly 
frozen to -80 and then liquid nitrogen on the next day. 
Bone marrow-derived macrophages (BMDM): BMDM were generated from total bone 
marrow cells cultured for 7 days in DMEM, 10% FCS, 20% L cell medium, 1 mM L-
Glutamine, penicillin/streptomycin as described previously3. Cells were plated at 1 x 
106 cells/well in a 12-well plate and cultured overnight in the presence of 100 ng/ml 
IFNγ (Peprotech). Macrophages were typically stimulated with 1 µg/ml LPS 
(S.abortus equi, Enzo Life Sciences) for 4 hours prior to functional characterization. 
Cells were rinsed once and stimulated in BSS buffer (0.13 M Na-gluconate, 0.02 M 
HEPES, 5 mM glucose, 5 mM glycine, 5 mM KCl, 1 mM MgCl2, pH 7.5) with 5 mM 
ATP (Roche) for 30’. Cell supernatants were cleared from debris in an Eppendorf 
centrifuge at 1000 rpm at 4ºC for 10’ and MP were recovered by centrifugation at 
16,000 g at 4ºC for 1 hour. Pellets were resuspended in 150 µl HBS (10 mM Hepes, 
pH 7.4, 137 mM NaCl, 5.3 mM KCl, 1.5 mM CaCl2) for FXa generation or 
prothrombinase assays and in SDS-sample buffer for Western Blotting.  
Functional assays: Cell surface TF activity was determined with 0.5 nM FVIIa (kindly 
provided by L. Petersen, Novo Nordisk) and 50 nM FX (Haematologic Technologies) 
in HBS by measuring a time course of FXa generation. TF MP activity was measured 
in HBS with 2 nM VIIa and 100 nM FX by determining a time course of FXa 
generation that was quantified after quenching in EDTA with the chromogenic 
substrate (Spectrozyme FXa, American Diagnostica). MP prothrombinase activity 
was measured in HBS with 10 nM FVa, 5 nM FXa and 500 nM prothrombin 
(Haematologic Technologies) at ambient temperature, and quantification of thrombin 
generation with the chromogenic substrate Spectrozyme TH (American Diagnostica). 
Western blotting: We used the following antibodies for detection of proteins 
associated with MP by Western blotting: polyclonal rabbit anti-mouse TF (R8084) 
and polyclonal anti-integrin β1 2, and anti-β-actin (Sigma-Aldrich). For detection of 
cell-associated TF, we prepared membrane fractions from cells using repeated 
Triton-X114 phase separation of cell lysed with 1% Triton-X114 (0.1 M Tris pH 8.5, 
10 mM EDTA, 1 mM PMSF) and solubilized the acetone washed detergent pellets in 
SDS-sample buffer (Invitrogen). 
RNA extraction and qPCR: RNA was isolated from macrophages using TRIzol 
Reagent (Life Technologies) and 1 µg RNA was transcribed into cDNA with 
SuperScript III First-Strand Synthesis System (Invitrogen). Transcript levels were 
quantified by Real Time PCR using SyBr Green Master Mix (Applied Biosystems) on 
an Applied Biosystems 7300 System and normalized for β-actin levels. We used an 
intron-spanning primer pair that was anchored in Exon 5 and only amplified flTF 
cDNA. 
 
Statistical analyses 
Data are indicated as mean ± SEM. Unpaired Student’s t-test was performed for 
comparison of two groups, and two-way ANOVA was used to compare 4 groups of 
two genotypes and both sexes. For comparison of genotype distributions a X2-test 
was applied. A p value <0.05 was considered as significant. Hematology data were 
analyzed using R-Scripts. Depending on the distribution of the respective data 
parametric or non-parametric statistical methods were used. 
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Supplemental Table 1: data table of significantly regulated genes in heart as well as 
lung tissue from male and female homozygous C213G/C213G TF mice compared to 
wt TF mice. Data provided as an Excel file. 
 
C213G/C213G	 wt	C213G/C213G	 wt	
Supplemental	Figure	1	
wt	 C213G/C213G	
male	 female	 male	 female	
Hemorrhages	in	heart	 0/5	 0/5	 5/10	 7/11	
Hemorrhages	in	lung	 1/5	 0/5	 5/10	 1/11	
Hemorrhages	in	brain	 0/5	 0/5	 2/10	 2/11	
E9.5 yolk sac histology showed similar erythrocyte filling and α-SMA expression in 
yolk sac vessels of homozygous C213G/C213G TF and wt embryos. At E14.5 dead 
homozygous C213G/C213G TF embryos were identified. Placentae of homozygous 
C213G/C213G TF embryos showed various degrees of blood pools. Placentas of 7 wt 
and 8 C213G/C213G TF mice were examined. 
Incidence of organ bleedings in male and female wt and homozygous C213G/C213G 
TF mice. 
A	
B	
Supplemental	Figure	2	
Normal morphology of seminiferous tubules of the testes and sperm density in the 
epididymides of C213G/C213G TF mice. Representative pictures of hematoxylin and 
eosin (H&E)-stained sections of (upper panel) testis and (lower panel) epididymis (caput 
and cauda) from wt and homozygous C213G/C213G TF mice are displayed. 10x (picture 
above) and 20x (below) magnifications are shown. 
A	
B	
		
		
Blood pressure and heart rate. Blood pressure and heart rate are unchanged in homozygous 
C213G/C213G TF as compared to wt TF mice, irrespective of gender. 
